OpenURL Connection Search

Select item for more details and to access through your institution.

Reversal of Docetaxel Resistance With Bevacizumab and Thalidomide.
Published in:
Clinical Genitourinary Cancer, 2009, v. 7, n. 2, p. E37, doi. 10.3816/CGC.2009.n.020
By:
- Ning, Yang-min;
- Figg, William D.;
- Dahut, William L.
Publication type:
Article
Acute aortic dissection in a hypertensive patient with prostate cancer undergoing chemotherapy containing bevacizumab.
Published in:
Acta Oncologica, 2008, v. 47, n. 8, p. 1600, doi. 10.1080/02841860801978905
By:
- Aragon-Ching, Jeanny B.;
- Ning, Yang-Min;
- Dahut, William L.
Publication type:
Article
Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer.
Published in:
BJU International, 2016, v. 118, n. 4, p. 590, doi. 10.1111/bju.13412
By:
- Madan, Ravi A.;
- Karzai, Fatima H.;
- Ning, Yang‐Min;
- Adesunloye, Bamidele A.;
- Huang, Xuan;
- Harold, Nancy;
- Couvillon, Anna;
- Chun, Guinevere;
- Cordes, Lisa;
- Sissung, Tristan;
- Beedie, Shaunna L.;
- Dawson, Nancy A.;
- Theoret, Marc R.;
- McLeod, David G.;
- Rosner, Inger;
- Trepel, Jane B.;
- Lee, Min‐Jung;
- Tomita, Yusuke;
- Lee, Sunmin;
- Chen, Clara
Publication type:
Article
Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013.
Published in:
Cancer (0008543X), 2014, v. 120, n. 19, p. 3025, doi. 10.1002/cncr.28809
By:
- Wissing, Michel D.;
- Kluetz, Paul G.;
- Ning, Yang‐Min;
- Bull, Jonca;
- Merenda, Christine;
- Murgo, Anthony J.;
- Pazdur, Richard
Publication type:
Article
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA‐Mutated Metastatic Castrate‐Resistant Prostate Cancer.
Published in:
Oncologist, 2021, v. 26, n. 2, p. 139, doi. 10.1002/onco.13585
By:
- Anscher, Mitchell S.;
- Chang, Elaine;
- Gao, Xin;
- Gong, Yutao;
- Weinstock, Chana;
- Bloomquist, Erik;
- Adeniyi, Oluseyi;
- Charlab, Rosane;
- Zimmerman, Sarah;
- Serlemitsos‐Day, Maritsa;
- Ning, Yang Min;
- Mayrosh, Ruth;
- Fuller, Barbara;
- Trentacosti, Ann Marie;
- Gallagher, Pamela;
- Bijwaard, Karen;
- Philip, Reena;
- Ghosh, Soma;
- Fahnbulleh, Frances;
- Diggs, Felicia
Publication type:
Article
FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin‐Containing Chemotherapy.
Published in:
Oncologist, 2019, v. 24, n. 4, p. 563, doi. 10.1634/theoncologist.2018-0084
By:
- Suzman, Daniel L.;
- Agrawal, Sundeep;
- Ning, Yang‐min;
- Maher, V. Ellen;
- Fernandes, Laura L.;
- Karuri, Stella;
- Tang, Shenghui;
- Sridhara, Rajeshwari;
- Schroeder, Jason;
- Goldberg, Kirsten B.;
- Ibrahim, Amna;
- McKee, Amy E.;
- Pazdur, Richard;
- Beaver, Julia A.
Publication type:
Article
Accelerating Early Access to Immunotherapies for Advanced Urothelial Carcinoma.
Published in:
2018
By:
- Ning, Yang‐Min;
- Maher, V. Ellen;
- Beaver, Julia A.;
- Goldberg, Kirsten B.;
- Blumenthal, Gideon M.;
- Pazdur, Richard
Publication type:
Editorial
FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum-Containing Chemotherapy.
Published in:
Oncologist, 2017, v. 22, n. 6, p. 743, doi. 10.1634/theoncologist.2017-0087
By:
- Ning, Yang‐Min;
- Suzman, Daniel;
- Maher, V. Ellen;
- Zhang, Lijun;
- Tang, Shenghui;
- Ricks, Tiffany;
- Palmby, Todd;
- Fu, Wentao;
- Liu, Qi;
- Goldberg, Kirsten B.;
- Kim, Geoffrey;
- Pazdur, Richard
Publication type:
Article
U.S. Food and Drug Administration Approval Summary: Enzalutamide for the Treatment of Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer.
Published in:
Oncologist, 2015, v. 20, n. 8, p. 960, doi. 10.1634/theoncologist.2015-0166
By:
- Ning, Yang‐Min;
- Brave, Michael;
- Maher, V. Ellen;
- Zhang, Lijun;
- Tang, Shenghui;
- Sridhara, Rajeshwari;
- Kim, Geoffrey;
- Ibrahim, Amna;
- Pazdur, Richard
Publication type:
Article
Accelerated Approval of Oncology Products: The Food and Drug Administration Experience.
Published in:
JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 8, p. 636, doi. 10.1093/jnci/djr062
By:
- Johnson, John R.;
- Ning, Yang-Min;
- Farrell, Ann;
- Justice, Robert;
- Keegan, Patricia;
- Pazdur, Richard
Publication type:
Article

Found: 10